Why the study?
Does the discontinuation of QT-prolonging drugs (amiodarone) and initiation of beta-blocker therapy prevent recurrent syncope and torsades de pointes in a patient with Andersen-Tawil syndrome?
Does the discontinuation of QT-prolonging drugs (amiodarone) and initiation of beta-blocker therapy prevent recurrent syncope and torsades de pointes in a patient with Andersen-Tawil syndrome?
Answers are grounded in this paper and cite their sources.
Recognizing prominent U waves is crucial for diagnosing Andersen-Tawil syndrome, as standard QT-prolonging antiarrhythmics like amiodarone can dangerously exacerbate repolarization abnormalities and trigger torsades de pointes.
A 26-year-old woman with recurrent syncope was diagnosed with Andersen-Tawil syndrome (ATS) following abnormal electrocardiographic (ECG) findings. Her history of ventricular arrhythmias and prominent U waves on ECG led to genetic testing, which identified a KCNJ2 mutation. This case underscores the importance of recognizing ATS-specific ECG patterns, including broad U waves, in diagnosing arrhythmias. Following medication adjustments, her symptoms improved, highlighting the significance of tailored treatment for ATS-associated arrhythmias.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: